A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions

Table 3

Prevalence of metabolic syndrome according to the three different criteria and gender.

		Total	%	Male	%	Female	%
		(n)		(n)		(n)
IDF	No MetS	1638	56.2	1279	68	339	34
	MetS	1275	43.8	603	32	658	66
WHO	No MetS	858	29.4	618	33	230	23
	MetS	2055	70.6	1264	67	767	77
ATP 111	No MetS	2070	71.1	1594	85	456	45
	MetS	843	28.9	288	15	541	55